Serum levels of the protein encoded by its gene targets ATG5 is presented as a biomarker for AIS patients [54], while another gene target, ATM is involved in neuroprotection in the initiation of protective mechanisms in ischemic preconditioning but promotes neuronal cell death following the ischemic insult [55]. This evidence concerns the gene ATM and androgen insensitivity syndrome.